Procter & Gamble Health | PGHL | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in June. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2016 | 2017 | 2018 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 2,793 | 2,782 | 12,434 | 6,391 | 4,689 |
Short-term investment |
| 278 | 762 | 0 | 0 | 0 |
Accounts receivables |
| 1,104 | 1,227 | 662 | 953 | 594 |
Inventories |
| 1,659 | 1,577 | 1,134 | 1,341 | 1,184 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Other current assets |
| 576 | 1,176 | 1,114 | 877 | 804 |
Total current assets |
| 6,410 | 7,523 | 15,343 | 9,562 | 7,271 |
Gross property plant... |
| 1,105 | 1,143 | 993 | 977 | 934 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 1,105 | 1,143 | 993 | 977 | 934 |
Work in Progress |
| 300 | 89 | 174 | 215 | 392 |
Miscellaneous Investment |
| 839 | 87 | 78 | 111 | 165 |
Deferred income taxes |
| 173 | 921 | 967 | 850 | 963 |
Intangible assets |
| 2 | 8 | 4 | 2 | 1 |
Goodwill |
| 0 | 0 | 0 | 0 | 0 |
Other long-term assets |
| 0 | 141 | 36 | 40 | 136 |
Total non-current assets |
| 2,419 | 2,389 | 2,252 | 2,196 | 2,590 |
Total assets |
| 8,828 | 9,912 | 17,595 | 11,757 | 9,862 |
Short-term debt |
| 0 | 0 | 0 | 0 | 0 |
Accounts Payable... |
| 751 | 833 | 914 | 1,240 | 1,288 |
Provisions |
| 651 | 392 | 236 | 44 | 19 |
Taxes Payable |
| 0 | 206 | 201 | 45 | 43 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 0 | 0 |
Other current liabilities |
| 682 | 822 | 609 | 945 | 1,041 |
Total current liabilities |
| 2,084 | 2,253 | 1,960 | 2,273 | 2,390 |
Long-term debt |
| 0 | 0 | 0 | 0 | 0 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 0 | 0 | 0 | 0 | 0 |
Provisions |
| 238 | 267 | 211 | 409 | 401 |
Capital Leases |
| 0 | 0 | 0 | 0 | 0 |
Other longterm liabilities |
| 51 | 60 | 22 | 12 | 34 |
Total non-current liabilities |
| 290 | 327 | 233 | 421 | 435 |
Total liabilities |
| 2,374 | 2,580 | 2,194 | 2,694 | 2,825 |
Share Capital |
| 166 | 166 | 166 | 166 | 166 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 6,289 | 7,167 | 15,235 | 8,897 | 6,871 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 | 0 |
Total Equity |
| 6,455 | 7,333 | 15,401 | 9,063 | 7,037 |
Total Liabilities and Equity |
| 8,828 | 9,912 | 17,595 | 11,757 | 9,862 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |